B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Tae 684

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Tae 684, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

lestaurtinib
280 shared targets
kw
238 shared targets
fedratinib
236 shared targets
r
223 shared targets
su
208 shared targets
nintedanib
197 shared targets
bosutinib
179 shared targets
tozasertib
176 shared targets
midostaurin
174 shared targets
ast
169 shared targets
Loading evidence profile...

This evidence profile for Tae 684 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.